PERK inhibitor delayed Purkinje cell degeneration, reduced the skeletal muscle abnormalities with improved motor performance during the symptomatic phase in a mouse model of Marinesco-Sjögren syndrome (Grande et al., 2018). This evidence concerns the gene EIF2AK3 and Marinesco-Sjogren syndrome.